On February 14, 2014, the Institutional Review Board approved an amendment to our ongoing Canadian study of MDMA-assisted psychotherapy for PTSD. The amended protocol, which includes changes to the MDMA …
On November 22, 2013, the first telephone screening took place in our new Canadian study of MDMA-assisted psychotherapy for 12 subjects with chronic, treatment-resistant PTSD. This marks the official start …
On September 6, 2013, Health Canada approved the amended protocol for our new Canadian study of MDMA-assisted psychotherapy in 12 subjects with chronic, treatment-resistant PTSD! After working for over …
On August 2, 2013, the amended protocol and other documents for our upcoming Canadian study of MDMA-assisted psychotherapy for PTSD were submitted for review by Health Canada. The Canadian Institutional …
On July 12, 2013, the Canadian Institutional Review Board approved the amended protocol and other documents for our upcoming Canadian study of MDMA-assisted psychotherapy for PTSD. The study will begin …
On June 25, 2013, MAPS submitted for review by a Canadian Institutional Review Board an amended protocol and other study documents for our upcoming Canadian study of MDMA-assisted psychotherapy for PTSD. …
On April 16, 2013, the nine grams of MDMA to be used in our upcoming Canadian study of MDMA-assisted psychotherapy for PTSD arrived at the study pharmacy. Our efforts to start the study began in 2007, …
On April 16, 2013, the nine grams of MDMA to be used in our upcoming Canadian study of MDMA-assisted psychotherapy for PTSD arrived at the study pharmacy. Our efforts to start the study began in 2007, …
On April 8, 2013, the nine grams of MDMA to be used in our upcoming Canadian study of MDMA-assisted psychotherapy for PTSD were exported from Switzerland to Canada. The Canadian pharmacist worked for more …
On February 13, 2013, our Canadian pharmacist received the corrected import permit from Health Canada, after working for more than 2½ years to make the required security adjustments to the pharmacy. …
On January 10, 2013, Co-Principal Investigator Ingrid Pacey, M.D., received authorization from Health Canada to store and administer the MDMA to be used in our upcoming Canadian study of MDMA-assisted …
On January 8, 2013, Health Canada issued the import license required to bring MDMA from Switzerland into Canada for our upcoming Canadian study of MDMA-assisted psychotherapy for PTSD. The Canadian Institutional …
